Literature DB >> 26721711

Paeoniflorin inhibits macrophage-mediated lung cancer metastasis.

Qi Wu1, Gang-Ling Chen2, Ya-Juan Li3, Yang Chen4, Fang-Zhen Lin4.   

Abstract

Alternatively activated macrophages are more frequently involved in tumor growth, angiogenesis, and immunosuppression. A previous study showed that paeoniflorin, the major active constituent of Paeonia lactiflora Pallas, can inhibit tumor growth and lung metastases of Lewis lung tumor-bearing mice. This study tried to investigate whether paeoniflorin inhibited lung cancer metastasis by inhibiting the alternative activation of macrophages (M2 macrophage). Using a viability assay, the cytotoxicity of paeoniflorin on Lewis lung cancer cells and peritoneal macrophages were investigated. In vitro scratch wound and in vivo lung metastasis experiments were used to test the ability to inhibit the migration of paeoniflorin and the function of M2 macrophages. Flow cytometry was performed to test the cell cycle of Lewis lung cancer cells, and to test the M2 macrophages in peritoneal macrophages and subcutaneous transplantable tumor. It was found that paeoniflorin showed no inhibitory effect on the growth of Lewis lung cancer cells and peritoneal macrophages of mouse in vitro. Paeoniflorin could attenuate the migration of LLC stimulated by alternatively activated macrophages (stimulated for 24 h and 48 h, paeoniflorin 1, 3, 10, 30, 100 μmol·L(-1), P < 0.01 or P < 0.05 vs control group). Paeoniflorin could decrease the cell populations at S phases (paeoniflorin 10, 30, 100 μmol·L(-1), P < 0.05 vs control group) and increase the cell populations at G0-G1 phases of Lewis lung cancer cells (paeoniflorin 100 μmol·L(-1), P < 0.05 vs control group) and reduce the numbers of M2 macrophages in peritoneal macrophages induced by IL-4 (paeoniflorin 1, 3, 10, 30, 100 μmol·L(-1), P < 0.01 vs Control group). Paeoniflorin could reduce lung metastasis of Lewis lung cancer cells xenograft and decrease the numbers of M2 macrophages in subcutaneous xenograft tumour in vivo (paeoniflorin 20, 40 mg·kg(-1), P < 0.01 vs control group). These results suggest that paeoniflorin could reduce lung metastasis of Lewis lung cancer cells xenograft partly through inhibiting the alternative activation of macrophages.
Copyright © 2015 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alternatively activated macrophages; Lung cancer; Metastasis; Paeoniflorin; Tumor-associated macrophages

Mesh:

Substances:

Year:  2015        PMID: 26721711     DOI: 10.1016/S1875-5364(15)30098-4

Source DB:  PubMed          Journal:  Chin J Nat Med        ISSN: 1875-5364


  11 in total

Review 1.  The role of integrins in TGFβ activation in the tumour stroma.

Authors:  Zareen Khan; John F Marshall
Journal:  Cell Tissue Res       Date:  2016-08-12       Impact factor: 5.249

2.  Paeoniflorin blocks the proliferation of vascular smooth muscle cells induced by platelet‑derived growth factor‑BB through ROS mediated ERK1/2 and p38 signaling pathways.

Authors:  Xianwei Fan; Jintao Wu; Haitao Yang; Lijie Yan; Shanling Wang
Journal:  Mol Med Rep       Date:  2017-11-15       Impact factor: 2.952

3.  Targeting Tumor Microenvironment: Effects of Chinese Herbal Formulae on Macrophage-Mediated Lung Cancer in Mice.

Authors:  Fei Xu; Wenqiang Cui; Zhengxiao Zhao; Weiyi Gong; Ying Wei; Jiaqi Liu; Mihui Li; Qiuping Li; Chen Yan; Jian Qiu; Baojun Liu; Jingcheng Dong
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-28       Impact factor: 2.629

4.  Paeoniflorin induces G2/M cell cycle arrest and caspase-dependent apoptosis through the upregulation of Bcl-2 X-associated protein and downregulation of B-cell lymphoma 2 in human osteosarcoma cells.

Authors:  Li-Bin Jin; Jian Zhu; Cheng-Zhen Liang; Li-Jiang Tao; Bing Liu; Wei Yu; Han Hui Zou; Jun-Jie Wang; Huimin Tao
Journal:  Mol Med Rep       Date:  2018-01-22       Impact factor: 2.952

Review 5.  Origins, Phytochemistry, Pharmacology, Analytical Methods and Safety of Cortex Moutan (Paeonia suffruticosa Andrew): A Systematic Review.

Authors:  Zhiqiang Wang; Chunnian He; Yong Peng; Feihu Chen; Peigen Xiao
Journal:  Molecules       Date:  2017-06-07       Impact factor: 4.411

6.  In vitro and in vivo effects of traditional Chinese medicine formula T33 in human breast cancer cells.

Authors:  Yu-Te Liu; Chao-Hsiang Hsiao; Bor-Show Tzang; Tsai-Ching Hsu
Journal:  BMC Complement Altern Med       Date:  2019-08-13       Impact factor: 3.659

7.  Comparative transcriptomics characterized the distinct biosynthetic abilities of terpenoid and paeoniflorin biosynthesis in herbaceous peony strains.

Authors:  Baowei Lu; Fengxia An; Liangjing Cao; Qian Gao; Xuan Wang; Yongjian Yang; Pengming Liu; Baoliang Yang; Tong Chen; Xin-Chang Li; Qinghua Chen; Jun Liu
Journal:  PeerJ       Date:  2020-04-20       Impact factor: 2.984

8.  Anti-Lung Cancer Targets of Radix Paeoniae Rubra and Biological Molecular Mechanism: Network Pharmacological Analyses and Experimental Validation.

Authors:  Yunfei Ma; Guangda Li; Mingwei Yu; Kexin Cao; Qiwei Li; Xu Sun; Guowang Yang; Xiaomin Wang
Journal:  Onco Targets Ther       Date:  2021-03-16       Impact factor: 4.147

9.  Paeoniflorin suppresses pancreatic cancer cell growth by upregulating HTRA3 expression.

Authors:  Yuejun Li; Lili Gong; Ruili Qi; Qian Sun; Xinxin Xia; Haihui He; Jianshu Ren; Ouning Zhu; Debin Zhuo
Journal:  Drug Des Devel Ther       Date:  2017-08-23       Impact factor: 4.162

10.  A Case of Recurrent Hepatocellular Carcinoma Acquiring Complete Remission of Target Lesion With Treatment With Traditional Chinese Medicine.

Authors:  Chen Jianxin; Xu Qingxia; Wang Junhui; Zheng Qinhong
Journal:  Integr Cancer Ther       Date:  2016-07-21       Impact factor: 3.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.